DHP Topical Anesthetic Gel Recall Issued
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Keystone Industries has initiated a voluntary Class II recall of DHP Topical Anesthetic Gel due to defective containers that may have incomplete seals.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 1, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, Drugs.
What Happened
Keystone Industries is conducting a voluntary recall of DHP Topical Anesthetic Gel after determining that some bottles may have incomplete seals.
Which Products Are Affected
The recall affects DHP Topical Anesthetic Gel, Benzocaine 20%, Strawberry Flavor, 1 oz. (30 g), NDC 69634-020-30. A total of 150 units with lot code BNZ-001921 and expiration date 04/15/2029 are involved. The products were distributed nationwide in the USA.
What You Should Do
The recall was initiated by the firm via letter. No additional consumer instructions are provided in the recall notice.
Why This Matters
This is a Class II recall involving a human OTC drug product distributed across the United States.
Source
FDA recall number D-0602-2026, event ID 99076.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (773 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 1, 2026.
Frequently Asked Questions
Common questions about this FDA recall.